Translational Science Laboratory

The Translational Science Laboratory (TSL) works closely with clinical and translational scientists to drive the development and utilization of novel biomarker assays to provide the most innovative pre-clinical and correlative science studies associated with early phase oncology clinical trials.

Operations Manager: Marty Romeo, Ph.D.
IHC: Melodie Parrish
Data/Imaging Analysis: Thierry Pecot, Ph.D.
Main Lab: Hollings Cancer Center - 506
Histology/IHC: Hollings Cancer Center- 510


Thierry Pecot

Hollings Cancer Center researcher Thierry Pécot, Ph.D. selected as a CZI Imaging Scientist and received a $1.1 million, five-year grant that will support his current research project to enable biologists to apply deep learning tools to their images.

 Hollings researcher receives funding to harness power of imaging

The mission of the TSL is to facilitate the translation of basic science research to the clinical setting and vice-versa with the ultimate intention of improving diagnosis and treatment strategies for cancer patients. The primary goals of the Translational Science Laboratory are to:

  • Conceive and execute a strategic, correlative science plan for clinical trials in the HCC
  • Be a central laboratory for clinical trial specimen acquisition and processing for downstream analyses
  • Develop and validate a portfolio of novel biomarker assays that are available for translational studies
  • Provide education to faculty and staff regarding novel technologies
  • Provide project management for studies that utilize resources available through other shared resources, investigator laboratories and outside vendors
  • Initiate collaborations and form strategic partnerships between HCC clinical investigators and pharmaceutical corporations

Services & Expertise

  • Clinical trial sample receiving, storage and distribution, tracked through web-based database
  • PBMC, plasma, serum and biopsy tissue processing
  • Automated Purification of DNA, RNA, miRNA from cells, blood, FFPE or fresh frozen tissue samples
  • Custom targeted cancer NGS library generation
  • Single-Cell Sequencing (10X Genomics)
  • Droplet digital PCR (BioRad QX200)
  • Immunohistochemistry including multiplex chromogenic and immunofluorescence assays
  • in situ hybridization
  • Protein purification and Enzyme-Linked Immunosorbent Assays (ELISA)
  • Data and imaging analysis
Back to top Back to top